CVE-2026-14959

CVE-2026-14959 is a critical-severity vulnerability in Ibm Aspera Faspex with a CVSS 3.x base score of 9.1. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-78.

Key facts

Description

IBM Aspera Faspex 5 5.0.0 through 5.0.15.4 could allow a remote authenticated attacker to execute arbitrary code due to shell command injection.

Frequently asked questions

What is CVE-2026-14959?
IBM Aspera Faspex 5 5.0.0 through 5.0.15.4 could allow a remote authenticated attacker to execute arbitrary code due to shell command injection.
How severe is CVE-2026-14959?
CVE-2026-14959 has a CVSS 3.x base score of 9.1, rated critical severity. It is exploitable over network with low attack complexity, requires high privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2026-14959 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (61st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-14959?
CVE-2026-14959 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2026-14959?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
When was CVE-2026-14959 published?
CVE-2026-14959 was published on 2026-07-28 and last updated on 2026-08-05.

References

Affected products (1)

More vulnerabilities in Ibm Aspera Faspex

All CVEs affecting Ibm Aspera Faspex →

Other CWE-78 (OS Command Injection) vulnerabilities

Browse all CWE-78 (OS Command Injection) vulnerabilities →